Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A, Barbui T.
Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26.
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Gangat N, Tefferi A.
Am J Hematol. 2021 Mar 1;96(3):354-366. doi: 10.1002/ajh.26067. Epub 2020 Dec 28.
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Gangat N, Singh A, Ilyas R, Loscocco GG, Elliott M, Begna K, Pardanani A, Tefferi A.
Am J Hematol. 2024 Oct;99(10):1862-1869. doi: 10.1002/ajh.27416. Epub 2024 Jun 12.
Essential thrombocythemia and pregnancy.
Griesshammer M, Heimpel H, Pearson TC.
Leuk Lymphoma. 1996 Sep;22 Suppl 1:57-63. doi: 10.3109/10428199609074361.
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, Shehata N.
JAMA Netw Open. 2019 Oct 2;2(10):e1912666. doi: 10.1001/jamanetworkopen.2019.12666.
First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin.
Leković D, Gotić M, Ljubić A.
Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):210-3. doi: 10.2298/sarh1504210l.
How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy.
Robinson SE, Harrison CN.
Br J Haematol. 2020 May;189(4):625-634. doi: 10.1111/bjh.16453. Epub 2020 Mar 9.
Contraceptive dilemmas.
Guthrie K, Searle S.
Practitioner. 1994 Aug;238(1541):567-9, 571-4.
Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.
Sakai K, Ueda A, Hasegawa M, Ueda Y.
Int J Hematol. 2018 Aug;108(2):203-207. doi: 10.1007/s12185-017-2397-8. Epub 2017 Dec 30.
Combined thrombophilic risk factors and essential thrombocythemia in patient with recurrent venous thromboembolic episodes-thirty-three-year follow-up.
Antonijevic N, Stanojevic M, Milosevic R, Djordjevic V, Jaukovic M, Vukcevic V, Kovac M, Mikovic D, Radojkovic D, Vasiljevic Z.
J Thromb Thrombolysis. 2005 Apr;19(2):93-5. doi: 10.1007/s11239-005-0783-1.
